StockUK listing UK0NZRLSEDefensive Anchor

Solvay SA(0NZR) Stock Analysis

EUR --+0.00%
Reward51Moderate
Risk13Low
50%Data
Thin 0% profit margin · Revenue down 6% YoY
EUR —+0.00 (+0.00%) Previous close · LSE
Market cap 8.49Bn
Reward Rating51 Moderate reward assessment · 50% data coverage
Bottom 50% of stocksView factors
Risk Rating13 Low risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on 0NZR to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Solvay SA?

Solvay SA provides basic and performance chemicals worldwide.

AI Brief Pro

The brief on Solvay SA

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Solvay SA?

Solvay SA provides basic and performance chemicals worldwide. The company engages in the production of sodium carbonate or soda ash and its derivatives used by customers in glass for building, solar panels, glass containers, and packaging; in lithium-ion batteries for electric vehicles; and for detergents and chemicals, as well as sodium bicarbonate for food and animal feed, and flue gas treatment or healthcare applications. The company is listed on the LSE in UK, with a market capitalisation of 8.49B, and a P/E ratio of 0.1x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Profitability metrics are mixed — margins may be under pressure.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (51)
Company Information
SectorN/A
IndustryN/A
P/E Ratio0.0719
Beta0.246
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.